Symptoms & Early Warning Signs
Common indicators and clinical warning signs
Note: Early-stage prostate cancer often has no symptoms. Many symptoms are also caused by benign prostatic hyperplasia (BPH). PSA testing and digital rectal exam are important for early detection.
Diagnosis Pathway
Step-by-step clinical evaluation and staging workflow
PSA (prostate-specific antigen) blood test
Digital rectal exam (DRE) to feel for abnormalities
Prostate biopsy (transrectal or transperineal) if PSA or DRE abnormal
MRI of prostate (may be done before biopsy)
Pathology report with Gleason score and staging
Imaging tests (bone scan, CT, MRI) if advanced disease suspected
Staging Explained
How tumor size, lymph node involvement, and metastasis are graded
Cancer confined to prostate, low PSA, low Gleason score
Cancer confined to prostate but higher PSA or Gleason score
Cancer spread beyond prostate capsule but not to distant sites
Cancer spread to lymph nodes or distant organs (bones, other organs)
Treatment Options
Standard of care modalities according to NCCN clinical guidelines
Active Surveillance
For low-risk, slow-growing cancers. Regular monitoring with PSA tests, DRE, and periodic biopsies. Treatment starts if cancer progresses.
Surgery (Prostatectomy)
Removal of entire prostate gland. Types: radical prostatectomy (open, laparoscopic, or robot-assisted). May include removal of lymph nodes. Can preserve nerves (nerve-sparing) to maintain erectile function.
Radiation Therapy
External beam radiation or brachytherapy (radioactive seeds). Used for localized disease or after surgery. Typically 7-9 weeks of daily treatment for external beam.
Hormone Therapy
Androgen deprivation therapy (ADT) to lower testosterone. Used for advanced disease or combined with radiation for high-risk localized disease. May include LHRH agonists or antagonists.
Chemotherapy
For advanced/metastatic prostate cancer that no longer responds to hormone therapy. Common drug: docetaxel.
Targeted Therapy/Immunotherapy
For advanced disease: PARP inhibitors (if genetic mutations), immunotherapy (sipuleucel-T), or other targeted agents.
Treatment Cost Comparisons
Transparent out-of-pocket benchmarks for India and US healthcare centers
Treatment Cost in India
- PSA test: ₹500 - ₹2,000
- Prostate biopsy: ₹15,000 - ₹50,000
- Robotic prostatectomy: ₹4-12 lakhs
- Open prostatectomy: ₹2-6 lakhs
- Radiation therapy: ₹2-5 lakhs
- Brachytherapy: ₹3-6 lakhs
- Hormone therapy: ₹5,000 - ₹20,000 per month
- Complete treatment: ₹3-20 lakhs (depending on stage and type)
Treatment Cost in US
- PSA test: $20 - $50
- Prostate biopsy: $1,000 - $3,000
- Robotic prostatectomy: $30,000 - $80,000
- Open prostatectomy: $20,000 - $60,000
- Radiation therapy: $15,000 - $60,000
- Brachytherapy: $20,000 - $50,000
- Hormone therapy: $500 - $2,000 per month
- Complete treatment: $30,000 - $200,000+
Frequently Asked Questions about Prostate Cancer
This guide provides verified clinical insights based on established oncological literature (NCCN, ASCO, ESMO). It is not a substitute for professional medical diagnosis or personalized treatment planning. Always consult your qualified oncology specialist before initiating treatment.